JP2004269517A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004269517A5 JP2004269517A5 JP2004041914A JP2004041914A JP2004269517A5 JP 2004269517 A5 JP2004269517 A5 JP 2004269517A5 JP 2004041914 A JP2004041914 A JP 2004041914A JP 2004041914 A JP2004041914 A JP 2004041914A JP 2004269517 A5 JP2004269517 A5 JP 2004269517A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- pseudoephedrine
- pharmaceutical composition
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000003839 salts Chemical class 0.000 claims 6
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 229960003908 pseudoephedrine Drugs 0.000 claims 5
- KWGRBVOPPLSCSI-WCBMZHEXSA-N pseudoephedrine Chemical compound CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WCBMZHEXSA-N 0.000 claims 5
- 229960001802 phenylephrine Drugs 0.000 claims 3
- SONNWYBIRXJNDC-VIFPVBQESA-N phenylephrine Chemical compound CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 claims 3
- 229940108858 belladonna total alkaloid Drugs 0.000 claims 2
- 206010039083 rhinitis Diseases 0.000 claims 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical class O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 claims 1
- 241001106067 Atropa Species 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 claims 1
- 230000001387 anti-histamine Effects 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 229940124599 anti-inflammatory drug Drugs 0.000 claims 1
- 230000003110 anti-inflammatory effect Effects 0.000 claims 1
- 239000000739 antihistaminic agent Substances 0.000 claims 1
- 229940092732 belladonna alkaloid Drugs 0.000 claims 1
- GERIGMSHTUAXSI-UHFFFAOYSA-N bis(8-methyl-8-azabicyclo[3.2.1]octan-3-yl) 4-phenyl-2,3-dihydro-1h-naphthalene-1,4-dicarboxylate Chemical compound CN1C(C2)CCC1CC2OC(=O)C(C1=CC=CC=C11)CCC1(C(=O)OC1CC2CCC(N2C)C1)C1=CC=CC=C1 GERIGMSHTUAXSI-UHFFFAOYSA-N 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- OEHAYUOVELTAPG-UHFFFAOYSA-N methoxyphenamine Chemical compound CNC(C)CC1=CC=CC=C1OC OEHAYUOVELTAPG-UHFFFAOYSA-N 0.000 claims 1
- 229960005405 methoxyphenamine Drugs 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 201000009240 nasopharyngitis Diseases 0.000 claims 1
- 229940065721 systemic for obstructive airway disease xanthines Drugs 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004041914A JP3987501B2 (ja) | 2003-02-19 | 2004-02-18 | 医薬組成物 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003040664 | 2003-02-19 | ||
| JP2004041914A JP3987501B2 (ja) | 2003-02-19 | 2004-02-18 | 医薬組成物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006313255A Division JP2007039473A (ja) | 2003-02-19 | 2006-11-20 | 医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004269517A JP2004269517A (ja) | 2004-09-30 |
| JP2004269517A5 true JP2004269517A5 (https=) | 2007-01-25 |
| JP3987501B2 JP3987501B2 (ja) | 2007-10-10 |
Family
ID=33134116
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004041914A Expired - Lifetime JP3987501B2 (ja) | 2003-02-19 | 2004-02-18 | 医薬組成物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3987501B2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9005652B2 (en) | 2006-07-25 | 2015-04-14 | Wyeth | Chewable tablet containing phenylephrine |
| JP5896806B2 (ja) * | 2012-03-28 | 2016-03-30 | ロート製薬株式会社 | 内服組成物 |
| CN102641367B (zh) * | 2012-05-19 | 2014-02-26 | 陈亚徽 | 通光散清咽止咳糖及冲剂 |
| JP6616968B2 (ja) * | 2014-06-25 | 2019-12-04 | 興和株式会社 | 医薬組成物 |
| CN104623586A (zh) * | 2014-12-25 | 2015-05-20 | 陆莎 | 一种治疗咳嗽的中药混合物 |
-
2004
- 2004-02-18 JP JP2004041914A patent/JP3987501B2/ja not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2346329B1 (en) | A method of inhibiting hepatitis c virus by combination of a 5,6-dihydro-1h-pyridin-2-one and one or more additional antiviral compounds | |
| JP2005524658A5 (https=) | ||
| TW200635897A (en) | Piperidine derivatives and their use as anti-inflammatory agents | |
| JP2007522094A5 (https=) | ||
| JP2005538121A5 (ja) | 多重遅延放出抗ウイルス物質産物、その使用法と製剤 | |
| JP2012502037A5 (https=) | ||
| JP2008523153A5 (https=) | ||
| CN103561744A (zh) | 3-(5-氨基-2-甲基-4-氧代喹唑啉-3(4h)-基)哌啶-2,6-二酮在治疗免疫相关性和炎症性疾病中的用途 | |
| SE0104341D0 (sv) | New use | |
| JP2007514005A5 (https=) | ||
| JP2002509074A5 (https=) | ||
| Rosini et al. | The bivalent ligand approach as a tool for improving the in vitro anti‐Alzheimer multitarget profile of dimebon | |
| NO20062061L (no) | Nye substituerte, 4-amino-tiazolo[4,5-D]pyriminder, nyttige som kjemokinreseptorantagonister, ESP. CX3CR1 | |
| UA85541C2 (ru) | Карбаматные производные хинуклидина и фармацевтическая композиции, которая содержит эти соединения | |
| JP2008110970A5 (https=) | ||
| JP2007515426A5 (https=) | ||
| JP2007523135A5 (https=) | ||
| EP4442321A3 (en) | Methods of treating sjögren's syndrome using a bruton's tyrosine kinase inhibitor | |
| JP2009517411A5 (https=) | ||
| JP2006515299A5 (https=) | ||
| JP2005522432A5 (https=) | ||
| JP2009518415A5 (https=) | ||
| JP2004269517A5 (https=) | ||
| JP2018039810A5 (https=) | ||
| WO2006138373A3 (en) | MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF |